Chia-I. Shen

发表

Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer

C. Chiu, C. Chiang, Hsu-Ching Huang, 2022, Scientific Reports.

Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer

C. Chiu, Yuh-Min Chen, C. Chiang, 2021, Scientific Reports.

Reduced FEV1 as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors

C. Chiu, Yuh-Min Chen, K. Chou, 2022, Frontiers in Medicine.

Epidermal growth factor receptor mutations in non–small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction–based assays

T. Chou, C. Chiu, Y. Yeh, 2020, Journal of the Chinese Medical Association : JCMA.

Double diaphragmatic contour

D. Tarng, Chih-Yu Yang, Chia-I. Shen, 2018, Abdominal Radiology.

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

S. Chiou, Yuh-Min Chen, Mong-Lien Wang, 2022, International journal of molecular sciences.

Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy.

C. Chiu, C. Chiang, Hsu-Ching Huang, 2019, Lung cancer.

Prognostic factors for advanced lung cancer patients with do-not-intubate order in intensive care unit: a retrospective study

Kuang-Yao Yang, Wei-Chih Chen, Chia-I Shen, 2022, BMC Pulmonary Medicine.

EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases

Ching-Jen Chen, Cheng-Chia Lee, Wan-Yuo Guo, 2022, Journal of Neuro-Oncology.

Natural history of lung squamous cell brain metastases in patients treated with radiosurgery: a thirty-year experience at a tertiary medical center

Ching-Jen Chen, Hsiu-Mei Wu, W. Guo, 2022, Journal of Neuro-Oncology.

Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis

T. Chou, C. Chiu, Yuh-Min Chen, 2022, Journal of Cancer Research and Clinical Oncology.

Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis

T. Chou, C. Chiu, Yuh-Min Chen, 2021, Targeted Oncology.

Impending myxedema coma as the initial presentation of lung cancer.

C. Chiu, Y. Yeh, Hsu-Ching Huang, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target

Chun-Yu Liu, L. Tseng, T. Chao, 2022, Medical Oncology.

Leukoencephalopathy in patients with brain metastases who received radiosurgery with or without whole brain radiotherapy

Hsiu-Mei Wu, W. Guo, C. Lin, 2022, Journal of Neuro-Oncology.

Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.

Ching-Jen Chen, Wan-Yuo Guo, Hsiu-Mei Wu, 2021, Journal of Neurosurgery.

Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI

C. Chiu, Yuh-Min Chen, C. Chiang, 2020, Targeted Oncology.

Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report

C. Chiu, Y. Yeh, Chia-I Shen, 2021, JTO clinical and research reports.

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer

C. Chiu, Han Chang, C. Chiang, 2022, Frontiers in Oncology.

Pneumatosis intestinalis induced by targeted therapy

C. Chiu, Chih-Jung Chang, Chia-I. Shen, 2020, Postgraduate Medical Journal.

Dynamic immune signatures of patients with advanced non–small-cell lung cancer for infection prediction after immunotherapy

C. Chiang, Hsu-Ching Huang, Yung-Hung Luo, 2024, Frontiers in Immunology.